MétaCan
Menu
← Retour à la cohorte
Enregistrement W4405040089 · doi:10.1182/blood-2024-203393

Evaluating the Effect of Hydroxyurea on Fertility in Individuals Identifying As Women

2024· article· en· W4405040089 sur OpenAlexaffabout
Vanessa Shao, Claire Jones, Ann Kinga Malinowski, Kevin H.M. Kuo, Richard Ward, John Aneke, Andrew Binding, Nadine Shehata

Notice bibliographique

RevueBlood · 2024
Typearticle
Langueen
DomaineMedicine
ThématiquePregnancy and preeclampsia studies
Établissements canadiensUniversity Health NetworkLunenfeld-Tanenbaum Research InstituteUniversity of TorontoMount Sinai HospitalWestern University
Organismes subventionnairesnon disponible
Mots-clésFertilityMedicinePsychologyPopulationEnvironmental health

Résumé

récupéré en direct d'OpenAlex

Introduction: The effect of sickle cell disease (SCD) and hydroxyurea on fertility has recently been emphasized. Low anti-Mullerian hormone (AMH), suggestive of diminished ovarian reserve (DOR) has been identified at earlier ages in individuals with SCD. Recent studies have also suggested that hydroxyurea use by women with SCD leads to DOR. DOR, however, does not necessarily indicate infertility as many women who have SCD have pregnancies while using hydroxyurea prior to and during pregnancy. The effect of SCD and hydroxyurea on fertility must be determined to guide counselling particularly the need for fertility preservation if needed. The purpose of the study was to determine whether hydroxyurea affects fertility in women with SCD. Methods: We conducted a cross-sectional study using a self-administered questionnaire. The questionnaire has been developed according to standard criteria using open ended and close ended questions and is web based. The questionnaire was piloted for validity, time to completion and clarity. This questionnaire is being distributed to individuals identifying themselves as women who have desired or had at least one pregnancy in the last 10 years and who provided informed consent. The participants are from the Blood Disorders Program at Toronto General Hospital and the Special Pregnancy Program at Mount Sinai Hospital in Toronto, Canada. The questionnaire includes questions about individual characteristics (e.g. SCD genotype), fertility issues, pregnancy and pregnancy loss history, hydroxyurea usage and compliance, as well as factors linked to DOR such as disease severity, obesity, iron overload, smoking, and past contraceptive use. The primary outcome is a composite of primary or secondary infertility defined as inability to conceive for > 1 year and/or the use of assisted reproductive techniques for infertility to achieve a pregnancy, and/or > 3, 1st trimester losses. The secondary outcomes are the frequency of the individual components of the primary composite outcome. Statistical Analysis: Univariate analysis will determine the effect of hydroxyurea, SCD genotype, stroke prior to pregnancy, kidney disease, use of oral contraception, smoking, regular transfusion program, hospitalization, and pre-pregnancy use of iron chelators on the composite outcome. Linear regression will be used for continuous variables including years using hydroxyurea, age at pregnancy, and pre-pregnancy weight. A multivariable regression model will be developed to determine the effects of hydroxyurea on the composite outcome while adjusting for other characteristics that could affect the outcome such as age at pregnancy. The study is approved by the Research Ethics Board at each site. Recruitment is ongoing to achieve the required sample size. Results: This is an interim analysis of 33 individuals with SCD who completed the questionnaire. Of these, 17 had attempted pregnancy, and 6 were using hydroxyurea during this time. The gestational age at which the 6 individuals discontinued hydroxyurea varied, with most stopping within the 1st trimester. Birth control was used by 4, and 4 smoked before pregnancy. Pregnancy was reported by 15, and 5 experienced miscarriages, 20% of whom were using hydroxyurea. Parity varied: 40%, 20%, 26.7%, and 6.7 % had 1, 2, 3, and ≥4 pregnancies, respectively. First pregnancies mostly occurred between ages 18-30 years, with similar distribution for last pregnancies. Miscarriages occurred mostly once (n=4) or 3 times (n=1), with n=1 in later trimesters. Fertility treatments were needed by 9.1%. Of the 3 individuals tested, 2 had low AMH levels, suggesting DOR. Additionally, 2 had difficulty conceiving after previous pregnancies, and 5 reported prolonged efforts to conceive while using hydroxyurea. Conclusion: The preliminary results describe the frequency of pregnancies and pregnancy loss in individuals with SCD. Further analysis of the completed cohort will attempt to delineate the effect of SCD and hydroxyurea on fertility. Addressing fertility issues is vital for individuals with SCD to ensure they receive the appropriate support and counselling for their reproductive health.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,003
score de la tête « metaresearch » (Gemma)0,006
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Observationnel · Signal consensuel: Observationnel
GenreSignal candidat: Empirique · Signal consensuel: Empirique
Score de désaccord entre enseignants0,003
Score d'incertitude au seuil0,013

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0030,006
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0000,000
Bibliométrie0,0010,000
Études des sciences et des technologies0,0000,000
Communication savante0,0000,000
Science ouverte0,0000,000
Intégrité de la recherche0,0000,000
Charge utile insuffisante (le modèle a refusé de juger)0,0010,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,048
Tête enseignante GPT0,375
Écart entre enseignants0,327 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeObservationnel
Domainenon disponible
GenreEmpirique

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2024
Routes d'admission2
Résumé présentoui

Explorer davantage

Même revueBlood→Même sujetPregnancy and preeclampsia studies→Travaux en français237 207→